AI Article Synopsis

  • The EFSA Panel evaluated the safety of hesperetin dihydrochalcone as a new flavoring substance, determining that it did not require a read-across with other flavonoids in a previous group assessment (FGE.32).
  • The Panel found no genotoxicity concerns and anticipated that hesperetin dihydrochalcone would be metabolized to harmless products, despite lacking direct ADME studies for this substance.
  • Although a 90-day study indicated potential effects on thyroid hormone levels, these were deemed non-adverse, and exposure estimates for both adults and children showed sufficient safety margins.

Article Abstract

The EFSA Panel on Food Additives and Flavourings (FAF) was requested to evaluate the safety of hesperetin dihydrochalcone [FL-no: 16.137] as a new flavouring substance, in accordance with Regulation (EC) No 1331/2008. The substance is structurally related to the group of flavonoids evaluated in FGE.32 and is the aglycone of neohesperidine dihydrochalcone. Based on the data provided for [FL-no: 16.137], the Panel considered that a read-across between hesperetin dihydrochalcone and the substances in FGE.32 is not needed. Nevertheless, the flavonoids evaluated in FGE.32 were considered in a cumulative exposure assessment. The information provided on the manufacturing process, the composition and the stability of [FL-no: 16.137] was considered sufficient. The Panel concluded that there is no concern with respect to genotoxicity. No absorption, distribution, metabolism and excretion (ADME) studies on [FL-no: 16.137] were provided, but studies investigating the ADME of neohesperidine dihydrochalcone were submitted. The Panel noted that [FL-no: 16.137] has the same fate in the organism, as that of neohesperidine dihydrochalcone and considered that [FL-no: 16.137] can be anticipated to be metabolised to innocuous products only. In a prenatal developmental toxicity study, no maternal or foetal toxicity was observed. In a 90-day toxicity study, indications were obtained that the substance affects thyroid hormone levels at all doses tested (100-1000 mg/kg bw per day). Since these changes were not accompanied by apical findings indicative of hypothyroidism, the Panel considered these hormonal effects as not adverse. Using 1000 mg/kg bodyweight (bw) per day as reference point, adequate margins of exposure were calculated for adults and children, when considering the chronic added portions exposure technique (APET) dietary exposure estimates. Cumulative chronic exposure estimates to [FL-no: 16.137] and the four structurally related substances evaluated in FGE.32 do not raise a safety concern. The use of [FL-no: 16.137] as food flavouring, under the proposed conditions of use, does not raise a safety concern.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11615513PMC
http://dx.doi.org/10.2903/j.efsa.2024.9091DOI Listing

Publication Analysis

Top Keywords

[fl-no 16137]
32
hesperetin dihydrochalcone
12
evaluated fge32
12
neohesperidine dihydrochalcone
12
[fl-no
8
16137]
8
flavonoids evaluated
8
panel considered
8
toxicity study
8
exposure estimates
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!